MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Novartis

  • Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals’ Patent
    Supreme Court Grants Emergency Pause on Ruling Disallowing Novartis Pharmaceuticals’ Patent
    The Supreme Court has granted a temporary emergency stay of a lower court order that Novartis Pharmaceuticals says would allow the development of as many as 20 generic versions of ...
    September 29, 2022BY Matthew Vadum
  • Novartis Reports Zolgensma Caused 2 Deaths From Liver Failure
    Novartis Reports Zolgensma Caused 2 Deaths From Liver Failure
    Novartis AG on Thursday reported two patient fatalities due to acute liver failure following treatment with Zolgensma gene ...
    August 16, 2022BY Reuters
  • Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma
    Novartis Loses Patent Appeal Over $2.8 Billion Multiple Sclerosis Drug Against Chinese Pharma
    A U.S. appeals court overruled its prior decision, deciding that the patent for Novartis AG’s blockbuster drug Gilenya ...
    June 30, 2022BY Marina Zhang
  • Novartis to Cut Up to 8,000 Jobs Globally
    Novartis to Cut Up to 8,000 Jobs Globally
    ZURICH—Novartis said on Tuesday a previously announced restructuring program could lead to 8,000 jobs being cut, or about ...
    June 29, 2022BY Reuters
  • Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has ...
    January 10, 2022BY Tom Ozimek
  • Novartis Says US Court Upholds Gilenya Patent
    Novartis Says US Court Upholds Gilenya Patent
    ZURICH—Novartis AG said on Tuesday a U.S. court of appeals upheld the validity of a dosage regimen patent ...
    January 5, 2022BY Reuters
  • Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    ZURICH—Novartis has signed an option, collaboration, and license agreement with BeiGene Ltd for anti-cancer therapy ociperlimab (BGB-A1217) to ...
    December 21, 2021BY Reuters
  • Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third ...
    November 27, 2021BY Reuters
  • Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Two drugmakers plan on testing a drug that blocks enzymes in COVID-19 patients on ventilators in the United States. ...
    May 6, 2020BY Zachary Stieber
  • Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...
    April 20, 2020BY Zachary Stieber
  • Novartis Korea Executives Charged With Bribing Doctors
    Novartis Korea Executives Charged With Bribing Doctors
    Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former ...
    August 13, 2016BY The Associated Press
  • New Drug Could Reduce Cardiovascular Deaths (Video)
    New Drug Could Reduce Cardiovascular Deaths (Video)
    Researchers have created a new drug believed to reduce cardiovascular deaths.  ​This new drug, LCZ696, was created by ...
    August 30, 2014BY Epoch Videos
TOP NEWS
  • Central Banks Bought 23 Tonnes of Gold in July
    NEW By Naveen Athrappully
    Central Banks Bought 23 Tonnes of Gold in July
  • America’s Battle Against Invasive Species
    2hr By Jacob Burg
    America’s Battle Against Invasive Species
  • Supreme Court Schedules Fall Arguments: What to Know
    2hr By Matthew Vadum
    Supreme Court Schedules Fall Arguments: What to Know
  • Appeals Court Rejects Trump Bid to Use Immigration Database for Voter Checks
    7hr By Troy Myers
    Appeals Court Rejects Trump Bid to Use Immigration Database for Voter Checks
  • Federal Government Backs Supreme Court Challenge to AR-15 Bans
    8hr By Bill Pan
    Federal Government Backs Supreme Court Challenge to AR-15 Bans
  • NTD 8th International Piano Competition Winners Announced
    12hr By NTD Newsroom
    NTD 8th International Piano Competition Winners Announced
  • New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
    12hr By Marina Zhang
    New PFAS Pesticides Are Entering Our Food System, Revealing a Conundrum
  • Kremlin Says Peace Talks Useful as US Envoys Leave Moscow for Kyiv
    13hr By Jacki Thrapp
    Kremlin Says Peace Talks Useful as US Envoys Leave Moscow for Kyiv
  • Labor Day Gas Prices Head for Record High
    14hr By Bill Pan
    Labor Day Gas Prices Head for Record High
  • Here’s What People Get Wrong About Modern Warfare | John Spencer
    18hr By Jan Jekielek, Epoch TV
    Here’s What People Get Wrong About Modern Warfare | John Spencer
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top